Significance, Mechanisms, and Progress of Anticancer Drugs Targeting HGF-Met

QR Code

Significance, Mechanisms, and Progress of Anticancer Drugs Targeting HGF-Met

None

Saved in:

Bibliographic Details
Main Authors:	Sakai, Katsuya, Nakamura, Takahiro, Suzuki, Yoshinori, Matsumoto, Kunio
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/23924
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Role of HGF/c-Met Pathway Signaling in Human Medulloblastoma
by: Faria, Claudia, et al.
Published: (2011)

Luteolin attenuates inflammation and apoptosis in LPS-induced ALI mice by activating the HGF/c-Met pathway
by: Jihong Bi, et al.
Published: (2025-07-01)

Cooperative CCL2/CCR2 and HGF/MET signaling enhances breast cancer growth and invasion associated with metabolic reprogramming
by: Wei Fang, et al.
Published: (2025-12-01)

A Dual Role of HGF-ERK Signaling in IL6/HGF-induced Hepatocyte ProliferationSummary
by: Jingwei Zhang, et al.
Published: (2025-01-01)

Endocrine Delivery System of NK4, an HGF-Antagonist and Anti-Angiogenic Regulator, for Inhibitions of Tumor Growth, Invasion and Metastasis
by: Mizuno, Shinya, et al.
Published: (2011)

Cardiotoxicity of Anticancer Drugs
by: I. Maiborodin, et al.
Published: (2025-02-01)

DENDRIMERS IN ANTICANCER TARGETED DRUG DELIVERY: ACCOMPLISHMENTS, CHALLENGES AND DIRECTIONS FOR FUTURE
by: A. M. Amjad
Published: (2021-06-01)

The c-Met receptor: Implication for targeted therapies in colorectal cancer
by: Elmira Safaie Qamsari, et al.
Published: (2017-04-01)

Electrochemical sensors for anticancer drugs used in the targeted therapy of chronic myeloid leukaemia
by: Totka Dodevska
Published: (2025-07-01)

Besparen met herhuisvesting? Een kostenvergelijking met thuisloosheid
by: Justine Carlier, et al.
Published: (2024-02-01)

Clinical and pathogenetic significance of angiogenesis factors (VEGF-A, HGF, IGF-1) in the development of cardiometabolic disorders in gout patients having different obesity phenotypes
by: T. A. Medvedeva, et al.
Published: (2021-04-01)

Atrial Fibrillation Associated with Anticancer Drugs
by: O. D. Ostroumova, et al.
Published: (2020-12-01)

Progressive microneedles for targeting and intelligent drug delivery
by: Jiaqi Li, et al.
Published: (2025-06-01)

Circular RNAs as Targets for Developing Anticancer Therapeutics
by: Jaewhoon Jeoung, et al.
Published: (2025-07-01)

Improving the Dosing Schedules of Targeted Anticancer Agents
by: Dominique Levêque
Published: (2025-06-01)

Prognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysis.
by: Zhi Peng, et al.
Published: (2014-01-01)

Drug design of an anticancer drug: QSAR modeling, and molecular docking
by: Sedigheh Aghayari
Published: (2025-09-01)

Cell Cycle Regulatory Proteins in Breast Cancer: Molecular Determinants of Drug Resistance and Targets for Anticancer Therapies
by: Ahmad, Aamir, et al.
Published: (2012)

A multi-target protein of hTERTR-FAM96A presents significant anticancer potent in the treatment of hepatocellular carcinoma
by: Meng-Yu Zhang, et al.
Published: (2017-04-01)

A DNA Repair Protein BRCA1 as a Potentially Molecular Target for the Anticancer Platinum Drug Cisplatin
by: Ratanaphan, Adisorn
Published: (2011)

PROGNOSTIC SIGNIFICANCE OF MET235/235THR POLYMORPHISMS OF GENE AGT FOR DEVELOPMENT OF CARDIOVASCULAR DISORDERS IN PROFESSIONAL SPORTSMEN
by: D. V. Muzhenya, et al.
Published: (2016-10-01)

Topical Administration of Anticancer Drugs for Skin Cancer Treatment
by: Taveira, Stephânia Fleury, et al.
Published: (2011)

Safety of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2024-04-01)

Efficacy of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2023-07-01)

Section VI. NEW APPROACHES TO ANTICANCER DRUG DEVELOPMENT
Published: (2016-12-01)

Hypoxic state and glycolysis as a possible anticancer therapeutic target
by: V. A. Koblyakov
Published: (2015-06-01)

Targeting Skin Neoplasms: A Review of Berberine’s Anticancer Properties
by: Anna Duda-Madej, et al.
Published: (2025-07-01)

Nieuw-Guinea in verband met Kolonisatie /
by: Vrijburg, B.
Published: (1934)

Zich met kinderen verplaatsen in Brussel?
by: Bertrand Montulet, et al.
Published: (2008-02-01)

Intervention Potential of a Recombinant Tarim Red Deer HGF Protein in a Mouse Model of Alcoholic Liver Disease
by: Hong Chen, et al.
Published: (2025-06-01)

The anticancer activity and mechanisms of She medicine herbs
by: Yunxuan Miao, et al.
Published: (2025-07-01)

Immunohistochemistry for assessing toxicity and mechanism of action of anticancer drugs during preclinical trials. From theory to practice
by: M. A. Dodokhova, et al.
Published: (2024-09-01)

Potential of primary drug prevention of cardiotoxicity in the context of anticancer therapy
by: Yu. A. Vasyuk, et al.
Published: (2023-01-01)

Computational Virtual Screening Towards Designing Novel Anticancer Drugs
by: Chen, Po-Yuan
Published: (2012)

Anticancer Drug Metabolism: Chemotherapy Resistance and New Therapeutic Approaches
by: Akhdar, Hanane, et al.
Published: (2012)

EPIGENETIC EFFECTS OF ENZASTAURIN – A NEW ASPECT IN THE MECHANISM OF ACTION OF AN ANTICANCER DRUG FROM PROTEIN KINASE INHIBITORS
by: V. P. Maksimova, et al.
Published: (2020-09-01)

Cardiotoxicity of anticancer drugs and radiotherapy in patients with hematologic malignancies and solid tumors
by: L. M. Kogoniya, et al.
Published: (2022-07-01)

Emerging Trends in the Application of Nanosuspension-Based Biomaterials for Anticancer Drug Delivery
by: Aldeeb MME, et al.
Published: (2025-07-01)

Towards New Anticancer Strategies by Targeting Cancer Stem Cells with Phytochemical Compounds
by: Tanveer, Sharif, et al.
Published: (2011)

A Review of Natural and Synthetic Chalcones as Anticancer Agents Targeting Topoisomerase Enzymes
by: François-Xavier Toublet, et al.
Published: (2025-06-01)